Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2022

01-01-2022 | Acute Liver Failure | DDS–SIRC COOPERATIVE CONFERENCES

AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia

Authors: Nilofar Najafian, Andrew T. Weber, Jonathan E. Zuckerman, Sarah Zhang, Sammy Saab, Gina Choi

Published in: Digestive Diseases and Sciences | Issue 1/2022

Login to get access

Abstract

A patient with systemic amyloidosis developed portal hypertension, acute liver failure and multiorgan dysfunction. Extensive testing was unrevealing for paraproteinemia, plasma cell dyscrasia, infectious, or inflammatory conditions. He was transferred to our institution for orthotopic liver transplant evaluation but was ultimately declined given clinical instability and dysautonomia. Post-mortem evaluation revealed extensive amyloid deposition in multiple organs determined to be AL-lambda amyloidosis.
Literature
1.
go back to reference Voulgarelis M, Mitroulis I, Tzioufas AG. Amyloidosis. In: Efthimiou P, ed. Springer: Cham; 2019; 297–311.CrossRef Voulgarelis M, Mitroulis I, Tzioufas AG. Amyloidosis. In: Efthimiou P, ed. Springer: Cham; 2019; 297–311.CrossRef
5.
go back to reference Norero B, Perez-Ayuso RM, Duarte I, Ramirez P, Soza A, Arrese M et al. Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis. Ann Hepatol. 2013;13:142–149.CrossRef Norero B, Perez-Ayuso RM, Duarte I, Ramirez P, Soza A, Arrese M et al. Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis. Ann Hepatol. 2013;13:142–149.CrossRef
11.
go back to reference Wang YD, Zhao CY, Yin HZ. Primary hepatic amyloidosis: a mini literature review and five cases report. Ann Hepatol. 2012;11:721–727.CrossRef Wang YD, Zhao CY, Yin HZ. Primary hepatic amyloidosis: a mini literature review and five cases report. Ann Hepatol. 2012;11:721–727.CrossRef
Metadata
Title
AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia
Authors
Nilofar Najafian
Andrew T. Weber
Jonathan E. Zuckerman
Sarah Zhang
Sammy Saab
Gina Choi
Publication date
01-01-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07253-2

Other articles of this Issue 1/2022

Digestive Diseases and Sciences 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.